Aviva PLC Baxter International Inc Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Baxter International Inc stock. As of the latest transaction made, Aviva PLC holds 19,250 shares of BAX stock, worth $561,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,250

Previous 19,273 0.12%

Holding current value

$561,715

Previous $644,000 13.35%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $755 - $925	-23 Reduced 0.12%	19,250 $730,000
Q2 2024 Aug 02, 2024	BUY	$32.87 - $43.55 $14,134 - $18,726	430 Added 2.28%	19,273 $644,000
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $3,636 - $4,201	-96 Reduced 0.51%	18,843 $805,000
Q4 2023 Feb 09, 2024	SELL	$31.71 - $38.95 $3.06 Million - $3.76 Million	-96,638 Reduced 83.61%	18,939 $732,000
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $1.76 Million - $2.32 Million	-47,081 Reduced 28.94%	115,577 $4.36 Million
Q2 2023 Aug 10, 2023	SELL	$39.98 - $47.68 $4.28 Million - $5.1 Million	-106,933 Reduced 39.66%	162,658 $7.41 Million
Q1 2023 May 12, 2023	BUY	$37.58 - $52.57 $921,123 - $1.29 Million	24,511 Added 10.0%	269,591 $10.9 Million
Q4 2022 Feb 09, 2023	SELL	$49.7 - $57.71 $691,824 - $803,323	-13,920 Reduced 5.37%	245,080 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $1.5 Million - $1.86 Million	-27,879 Reduced 9.72%	259,000 $14 Million
Q2 2022 Aug 04, 2022	BUY	$63.83 - $80.0 $4.59 Million - $5.75 Million	71,858 Added 33.42%	286,879 $18.4 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $3.79 Million - $4.41 Million	49,255 Added 29.71%	215,021 $16.7 Million
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $890,142 - $1.04 Million	11,937 Added 7.76%	165,766 $14.2 Million
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $999,362 - $1.13 Million	-13,547 Reduced 8.09%	153,829 $12.4 Million
Q2 2021 Aug 10, 2021	SELL	$80.5 - $88.01 $200,284 - $218,968	-2,488 Reduced 1.46%	167,376 $13.5 Million
Q1 2021 May 13, 2021	BUY	$76.38 - $86.03 $119,305 - $134,378	1,562 Added 0.93%	169,864 $14.3 Million
Q4 2020 Feb 10, 2021	BUY	$75.39 - $82.36 $295,302 - $322,604	3,917 Added 2.38%	168,302 $13.5 Million
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $385,461 - $446,482	-4,921 Reduced 2.91%	164,385 $13.2 Million
Q2 2020 Aug 13, 2020	SELL	$78.66 - $94.14 $25,013 - $29,936	-318 Reduced 0.19%	169,306 $14.6 Million
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $1,646 - $2,145	23 Added 0.01%	169,624 $13.8 Million
Q4 2019 Feb 10, 2020	SELL	$76.7 - $88.45 $63,737 - $73,501	-831 Reduced 0.49%	169,601 $14.2 Million
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $870,003 - $959,568	-10,688 Reduced 5.9%	170,432 $14.9 Million
Q2 2019 Jul 30, 2019	SELL	$73.44 - $82.41 $598,315 - $671,394	-8,147 Reduced 4.3%	181,120 $14.8 Million
Q1 2019 May 14, 2019	BUY	$64.48 - $81.31 $45,974 - $57,974	713 Added 0.38%	189,267 $15.4 Million
Q4 2018 Feb 12, 2019	SELL	$61.45 - $77.8 $3.28 Million - $4.15 Million	-53,315 Reduced 22.04%	188,554 $12.4 Million
Q3 2018 Nov 13, 2018	SELL	$70.71 - $77.75 $629,460 - $692,130	-8,902 Reduced 3.55%	241,869 $18.6 Million
Q2 2018 Aug 01, 2018	SELL	$63.43 - $75.41 $230,377 - $273,889	-3,632 Reduced 1.43%	250,771 $18.5 Million
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $1.45 Million - $1.67 Million	-23,167 Reduced 8.35%	254,403 $16.5 Million
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $2.44 Million - $2.63 Million	-39,756 Reduced 12.53%	277,570 $17.9 Million
Q3 2017 Nov 13, 2017	SELL	$59.5 - $64.61 $118,405 - $128,573	-1,990 Reduced 0.62%	317,326 $19.9 Million
Q2 2017 Aug 07, 2017	BUY	N/A	319,316	319,316 $19.3 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account